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I n patients with a history of anaphylaxis induced by muscle relaxants,  an alternative method for achiev-
ing muscle relaxation during surgery is needed,  but few 
guidelines and review articles are available regarding 
such alternatives [1].  Anesthesiologists thus encounter 
the predicament of how to provide adequate muscle 
relaxation without muscle relaxants.  Theoretically,  the 
addition of spinal and epidural anesthesia to general 
anesthesia could achieve stable muscle relaxation,  but 
an increased use of local anesthetics can cause local 
anesthetic systemic toxicity (LAST).
Here,  we report a case in which LAST occurred after 
abdominal surgery performed under general anesthesia 
with combined spinal-epidural anesthesia,  in a patient 
with a history of anaphylaxis induced by rocuronium 
bromide.
Case Report
A 71-year-old Japanese woman (60 kg,  152 cm,  body 
mass index 26.0 kg/m2) was admitted to the hospital 
with lower abdominal pain and was diagnosed with a 
left iliopsoas muscle abscess and pyonephrosis.  She had 
diabetes mellitus preoperatively.  Her surgical history 
included a total abdominal hysterectomy with bilateral 
salpingo-oophorectomy,  a uterine sarcoma resection,  
endovascular stent grafting into the left common iliac 
artery,  and coil embolization of the left internal iliac 
artery.  She had no allergies and no significant family 
history on admission.  Laboratory test results were 
within normal ranges,  with the exception of a white 
blood cell count at 14,790 µl−1 and a C-reactive protein 
level at 25.47 mg/dl.
A computed tomography scan indicated that the 
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abscess cavity extended from a stent in the left common 
iliac artery to the plug in the left internal iliac artery,  
and it showed that stent occlusion had induced collat-
eral inflow vessel development in the left leg.  We ini-
tially chose to create a femoro-femoral bypass before 
abscess drainage.  During the induction of general anes-
thesia for the bypass surgery,  an anaphylactic reaction 
occurred,  including hypotension,  tachycardia and sys-
temic erythema; the surgery was thus cancelled.
The result of an intradermal test conducted 20 days 
later suggested a causative role for rocuronium bromide 
and remifentanil,  and it revealed a cross-sensitivity to 
vecuronium bromide.  We then completed a femoro- 
femoral bypass with the patient under general anesthe-
sia without muscle relaxants or remifentanil.  We 
planned to remove the patient’s artificial materials and 
perform intraperitoneal drainage and a left nephrec-
tomy with her under general anesthesia with combined 
spinal-epidural anesthesia and without muscle relaxants 
or remifentanil.
The patient was monitored by electrocardiography,  
noninvasive blood pressure (BP) recording,  and pulse 
oximetry in the operating room.  Her vital signs were 
normal: BP 121/75 mmHg,  heart rate (HR) 89 beats/
min,  and SpO2 94% on room air.  We inserted an epi-
dural catheter (Th12/L1) and confirmed that there was 
no backflow of cerebrospinal fluid or blood; we subse-
quently administered 20 mg isobaric bupivacaine into 
the subarachnoid space.  We used 40 mg of propofol 
and 200 µg fentanyl for the induction of general anes-
thesia and then intubated the patient with the inhala-
tion of 3% isoflurane with a spray of 4% lidocaine onto 
the vocal cords.
Anesthesia was maintained with 0.7-1.2% isoflurane 
and the administration of fentanyl as required.  After the 
effect of spinal anesthesia had diminished,  we adminis-
tered 0.2% ropivacaine and 1.5-2% lidocaine through 
the epidural catheter.  The time course of the dosages of 
intraoperative local anesthetics during surgery is shown 
in Fig. 1.  A rectal perforation was identified intraoper-
atively; a colostomy was thus added to the scheduled 
surgical procedures.  Lidocaine was administered as a 
bolus in addition to a ropivacaine infusion when we 
determined that muscle relaxation was inadequate.  The 
patient’s vital signs were stable: SpO2 99%,  HR 70- 
100 beats/min,  and systolic BP 90-130 mmHg.  There 
were no adverse events such as arrhythmia.
The durations of surgery and anesthesia were 10 h 
29 min and 12 h 31 min,  respectively.  The total vol-
umes of fluid and blood transfusions,  intraoperative 
blood loss,  and urine output were 6,230 ml (red blood 
cells,  1,680 ml; fresh frozen plasma,  1,200 ml; plate-
lets,  200 ml),  2,855 ml,  and 1,300 ml,  respectively.  
The total dosages of ropivacaine and lidocaine were 
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40 mg (0.67 mg/kg) and 690 mg (11.5 mg/kg),  respec-
tively.
After surgery,  the patient breathed spontaneously 
and opened her eyes,  although she could not follow 
simple verbal instructions.  Her pupils were equally 
2.5 mm in size.  We extubated the patient after a confir-
mation of adequate laryngo-pharyngeal and esopha-
geal-bronchial reflexes in the operating room.  Her 
cardiorespiratory status was stable.  After transfer to the 
intensive care unit,  the recovery of consciousness 
remained insufficient and the patient showed involun-
tary movements of her extremities.  Because LAST was 
suspected based on the intraoperative dosages of local 
anesthetics,  we intravenously administered 100 ml of a 
20% lipid emulsion.  The patient’s consciousness and 
involuntary movements immediately improved; she 
was able to speak and complain of pain.  She was 
uneventfully discharged to the ward on the third post-
operative day.
Discussion
Abdominal surgery for this patient with a history of 
muscle relaxant-induced anaphylaxis was completed 
under general anesthesia with epidural and spinal anes-
thesia and without any muscle relaxants.  Postopera-
tively,  the patient showed delayed emergence and 
involuntary movements of the extremities caused by 
LAST,  which improved after an intravenous injection of 
lipid emulsion.
Regional anesthesia,  including epidural anesthesia,  
is an effective approach to achieve muscle relaxation 
without the use of muscle relaxants.  The use of a high 
concentration of local anesthetics can block thick and 
long motor fibers during epidural anesthesia [2-4].  
However,  there is no objective method to evaluate the 
degree of muscle relaxation at this time.  We adminis-
tered primarily a ropivacaine infusion; we added a 
bolus of lidocaine when motor fiber blocking was 
needed to secure a surgical field or when the surgeon 
required muscle relaxation.  We might thus have used an 
excess of local anesthetics.
The appropriate dosage of lidocaine to block motor 
fibers has not been reported.  Becker et al.  proposed that 
the maximum individual dose of lidocaine without epi-
nephrine should not exceed 4.5 mg/kg of the patient’s 
body weight and that the maximum total dose should 
not exceed 300 mg for normal healthy adults [5].  They 
also contended that the maximum recommended indi-
vidual dose of lidocaine with epinephrine should not 
exceed 7 mg/kg; the maximum total dose should not 
exceed 500 mg [5].
LAST is associated with the absorption of anesthetic 
agents,  metabolic efficiency and muscle mass,  as well as 
the total amount of local anesthetics [6].  The reported 
risk factors of LAST are age (< 16 or > 60 years old),  
smaller muscle volume (particularly with regard to neo-
nates,  infants,  and weakened elderly patients),  female 
gender,  and comorbidities (primarily cardiac diseases,  
liver disease,  diabetes mellitus,  etc.) [6].  Our patient 
had three risk factors: age,  female gender,  and diabetes 
mellitus.
The plasma lidocaine concentration during epidural 
anesthesia reaches a peak level within 15-20 min and 
then decreases gradually; repeating the injection grad-
ually increases the concentration [7].  In our patient’s 
case,  the dosage of lidocaine used as local anesthesia 
was 450 mg in the last 4 h of the surgery.  Thus,  the 
LAST observed in our patient could have occurred 
because of the intraoperative dosage of local anesthetics,  
her clinical symptoms,  and the immediate effect of the 
intravenous lipid emulsion,  which has been described 
as an effective treatment for LAST in some guidelines 
[6 , 8].  The use of a 20% lipid emulsion for LAST was 
officially permitted by our institutional committee 
because it had not yet been approved in Japan.
Importantly,  some precautions can be taken to pre-
vent LAST during surgery involving muscle relaxation 
with local or regional anesthesia,  including the reduc-
tion of the total amount of local anesthetics as much as 
possible.  First,  combined spinal-epidural anesthesia is 
a good choice,  and continuous spinal anesthesia may 
provide an option to maintain muscle relaxation using a 
lower dose of local anesthetics.  Second,  local anesthet-
ics containing epinephrine are useful because epineph-
rine can limit the maximal blood concentration and 
prolong the period of peak concentration [9].  A recent 
study reported that a combined epidural injection of 
local anesthetics with fentanyl or dexmedetomidine 
augments the duration and quality of epidural anesthe-
sia and analgesia [10 , 11]; therefore,  this combined 
injection may reduce the overall requirement for local 
anesthetics.
In conclusion,  we treated LAST that occurred after 
an abdominal surgery under general anesthesia with 
combined spinal-epidural anesthesia in a patient with a 
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history of anaphylaxis induced by muscle relaxants.  
When patients with contraindications for the use of a 
muscle relaxant undergo surgery with epidural anesthe-
sia,  the cumulative amount of local anesthetics may be 
high,  especially during a long surgery; some precau-
tions are thus needed to prevent LAST.
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